低风险孤立性冠状动脉旁路移植术或单瓣膜手术患者术前贫血的意外影响:贫血管理中不应忽视这类患者
该研究基于2011至2022年全州登记数据(N=29,828)分析成人孤立性冠状动脉旁路移植术或单瓣膜手术患者,发现术前血细胞比容较高与STS定义的主要并发症/死亡风险降低相关(比值比0.96,P<.001),且血细胞比容与STS预测死亡风险的交互作用显著(比值比1.01,P<.001),在STS风险最低的患者中关联更强。
要点
- 术前血细胞比容较高与主要并发症/死亡风险降低相关(比值比0.96,P<.001)。
- 血细胞比容与STS预测死亡风险的交互作用显著(比值比1.01,P<.001)。
- STS风险最低的患者中,血细胞比容与主要并发症/死亡的关联更强。
核心结论
- 与风险较高的患者相比,风险较低的患者术前血细胞比容与主要并发症和死亡的关联更强。
- 所有风险组均需进行术前贫血管理以改善结局。
研究设计与样本
- 研究纳入2011至2022年全州登记数据库中成人孤立性冠状动脉旁路移植术或单瓣膜手术患者,共29,828例。
- 采用回归分析评估术前血细胞比容对STS定义的主要并发症/死亡的影响,并将血细胞比容与STS预测死亡风险作为连续变量分析其交互作用。
主要发现
- 中位年龄66岁(58-73岁),STS预测死亡风险1.02%(0.58%-1.99%),术前血细胞比容39.5%(35.8%-42.8%)。
- 样本包括78%孤立性冠状动脉旁路移植术(n=23,261)、10%孤立性二尖瓣修复/置换(n=3,119)、12%孤立性主动脉瓣置换(n=3,448),29%为女性(n=8,646)。
- 多变量分析发现较高的血细胞比容与STS定义的主要并发症/死亡风险降低相关(比值比0.96,P<.001)。
- 这些血细胞比容效应在调整术中输血后仍持续存在。
- 血细胞比容与STS预测死亡风险的交互作用对主要并发症/死亡显著(比值比1.01,P<.001)。
关键数值与推荐
- 较高的血细胞比容与STS定义的主要并发症/死亡风险降低相关(比值比0.96,P<.001)。
- 血细胞比容与STS预测死亡风险的交互作用对主要并发症/死亡显著(比值比1.01,P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Preoperative anemia is prevalent in cardiac surgery and independently associated with increased risk for short-term and long-term mortality. The purpose of this study was to examine the effect of preoperative hematocrit (Hct) on outcomes in cardiac surgical patients and whether the effect is comparable across levels of Society of Thoracic Surgeons Predicted Risk of Mortality (STS PROM). METHODS: The study consisted of adult, isolated coronary artery bypass grafting (CABG) or single-valve surgical patients in a statewide registry from 2011 to 2022 (N = 29,828). Regressions were used to assess effect of preoperative Hct on STS-defined major morbidity/mortality including the interaction of Hct and STS PROM as continuous variables. RESULTS: Median age was 66 years (58-73 years), STS PROM was 1.02% (0.58%-1.99%), and preoperative Hct was 39.5% (35.8%-42.8%). The sample consisted of 78% isolated CABG (n = 23,261), 10% isolated mitral valve repair/replacement (n = 3119), 12% isolated aortic valve replacement (n = 3448), and 29% were female (n = 8646). Multivariable analyses found that greater Hct was associated with reduced risk of STS-defined morbidity/mortality (odds ratio, 0.96; P < .001). These effects for Hct persisted even after adjustment for intraoperative blood transfusion. The interaction of Hct and STS PROM was significant for morbidity/mortality (odds ratio, 1.01; P < .001). There was a stronger association between Hct levels and morbidity/mortality risk in the patients with the lowest STS risk compared with patients with the greatest STS risk. CONCLUSIONS: Patients with lower risk had a greater association between preoperative Hct and major morbidity and mortality compared with patients with greater risk. Preoperative anemia management is essential across all risk groups for improved outcomes.
引用
- Hensley NB, Holmes SD, Cho BC, et al. Unexpected impact of preoperative anemia in low-risk isolated coronary artery bypass grafting or single-valve surgical patients: Do not overlook these patients in anemia management! J Thorac Cardiovasc Surg. 2023. PMID: 37839659. doi:10.1016/j.jtcvs.2023.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。